Tag Archive: low-molecular-weight heparin (LMWH)

Dec 19

Patients with atrial fibrillation (AF) who are bridged with low-molecular-weight heparin (LMWH)

Patients with atrial fibrillation (AF) who are bridged with low-molecular-weight heparin (LMWH) or unfractionated heparin during procedures requiring an interruption of oral anticoagulation tend to be at a higher risk of adverse events than patients who are not bridged, suggests a new analysis published in Circulation.

Sep 26

Most treatment strategies used to treat acute venous thromboembolism (VTE)

Most treatment strategies used to treat acute venous thromboembolism (VTE) appear to be as safe and effective as the currently recommended combination of low-molecular-weight heparin (LMWH) plus a vitamin K antagonist; however, they are not interchangeable, suggests a large network analysis published recently in JAMA.